Your browser doesn't support javascript.
loading
Prognostic role of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with metastatic castration resistant prostate cancer treated with abiraterone or enzalutamide.
Sciarra, Alessandro; Gentilucci, Alessandro; Cattarino, Susanna; Salsiccia, Stefano; Mariotti, Gianna.
Affiliation
  • Sciarra A; Department of Urology, Sapienza University, Rome, Italy - alessandro.sciarra@uniroma1.it.
  • Gentilucci A; Department of Urology, Sapienza University, Rome, Italy.
  • Cattarino S; Department of Urology, Sapienza University, Rome, Italy.
  • Salsiccia S; Department of Urology, Sapienza University, Rome, Italy.
  • Mariotti G; Department of Urology, Sapienza University, Rome, Italy.
Minerva Urol Nephrol ; 73(6): 863-865, 2021 Dec.
Article in En | MEDLINE | ID: mdl-35144373
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms, Castration-Resistant / Neutrophils Type of study: Prognostic_studies Limits: Humans / Male Language: En Journal: Minerva Urol Nephrol Year: 2021 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms, Castration-Resistant / Neutrophils Type of study: Prognostic_studies Limits: Humans / Male Language: En Journal: Minerva Urol Nephrol Year: 2021 Document type: Article